Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new method to find anti-depressant treatments that work for individual patients is about to be tested at GP surgeries across Europe. Researchers at the Oxford Health NHS Foundation Trust and Oxford University’s Department of Psychiatry, in collaboration with the Oxfordshire based company P1vital Products Ltd, are conducting the PReDicT (Predicting Response to Depression Treatment) study.

There are many anti-depressant drugs currently on the market, and different drugs seem to work on different people. But it generally takes between 4-6 weeks of treatment before people with depression start feeling better, and many people will not respond to initial anti-depressant drugs prescribed. This means that it often takes months to find an effective treatment for a patient.

Dr Michael Browning, a consultant psychiatrist at Oxford Health NHS Foundation Trust, a researcher at Oxford University’s Department of Psychiatry and  P1vital's medical director, is testing a new method which might find the right drug faster.

Read more

Similar stories

Reducing fat in the diabetic heart could improve recovery from heart attack

New research from the Department of Physiology, Anatomy and Genetics has shown that in type 2 diabetes an overload of lipids reduces the heart’s ability to generate energy during a heart attack, decreasing chances of recovery.

Brain cortex may regulate the need for sleep

Why we sleep, and the processes behind sleep, are amongst the most interesting questions in modern neuroscience.

New data show rise in hospital admissions for unvaccinated pregnant women

The Chief Midwifery Officer for England will urge expectant mums to have their COVID-19 vaccination as soon as possible. This follows a worrying rise in unvaccinated women being admitted to hospital with severe COVID-19, and evidence that the Delta variant poses a significantly greater risk than all previous strains.

Cooking with coal or wood associated with increased risk of major eye diseases

A study involving nearly half a million people in China reveals a clear link between cooking with wood or coal, and an increased risk of major eye diseases that can lead to blindness, according to a report published today in PLOS Medicine.

The mental health impacts of being an Olympian

Dr David M. Lyreskog, Postdoctoral Researcher, Department of Psychiatry explores the topic in detail.

Oxford's COVID African Innovation Seed Fund announced

Five graduate students currently studying at Oxford, including two Medical Sciences students, have been awarded £1,000 grants from the Vice Chancellor’s COVID-19 African Innovation Seed Fund for entrepreneurial projects aimed at addressing global challenges stemming from the pandemic.